v3.25.2
Reportable Segments
12 Months Ended
Dec. 31, 2024
Reportable Segments  
Reportable Segments

Note 15 Reportable Segments

Subsequent to the Business Combination in June 2024 (see Note 4 Business Combination), the Company hastworeportable segments: Technology and Telehealth. These two reportable segments align with the two legacy operating entities (VSee Lab and iDoc) which merged together upon the closing of the Business Combination. Operating segments are defined as components of an enterprise where separate financial information is evaluated regularly by a chief operating decision maker (CODM) in deciding how to allocate resources and assess performance. As of December 31, 2024, the Company’s CODM role was shared between the two Co-CEOs.

 

The CODM reviews gross margin and income (loss) from operations from our reportable segments to evaluate budgets and forecasts, assess actual performance and allocate resources. The CODM review focuses on month to month and quarter to quarter changes in these profit measures in order to identify potential future liquidity issues, evaluate performance and need for potential cost reductions and identify potential vendor sourcing changes. The CODM also reviews the operating segment’s assets, which mainly includes review of the accounts receivable accounts.

 

Our reportable segments are described below. The Company has no inter-segment revenues.

 

Telehealth Services – The Company’s proprietary technology platform and modular software solution empower users to plug and play telehealth services with end-to-end encrypted video streaming integrated with medical device data, electronic medical records, and other sensitive data, with multiple other interactive functionalities that enable teamwork that the Company believes are not available from any other system worldwide.

 

Healthcare Technology - The Company’s core platform is a highly scalable, integrated, application program interface (“API”) driven technology platform, for virtual healthcare delivery, with multiple real-time integrations spanning the healthcare ecosystem. The platform’s APIs power external connectivity and deep integration with a wide range of payors, electronic medical records, third-party applications, and other interfaces with employers, hospital systems, and health systems, which we believe uniquely positions us as a long-term partner meeting the unique needs of the rapidly changing healthcare industry. The Company will also be able to white label our solutions so they fit into the plans and strategies of our clients, all on a platform that is high-performance and highly scalable.

 

The accounting policies of our reportable segments are the same as those described in the “Summary of Significant Accounting Policies” for the Company. In addition, the Company currently operates in one primary geographic area (the United States) and as such, the disclosures below are attributable to that geographic area.

 

Revenue and costs are generally directly attributed to our segments, based on the historical separation of these two operating segments (as prior separate operating entities). In addition, the Company incurs certain costs at the corporate level, which generally include legal, finance and accounting, consulting, investor relations and insurance costs, as well as certain executive compensation costs. These costs recorded at the corporate level are not allocated to the operating segments, and are reflected as the “Unallocated corporate overhead expenses” in the summary tables below.

For the Year Ended December 31, 2024

Technology

Telehealth

Total

Revenues:

Subscription fees

$ 4,115,126

$ -

$ 4,115,126

Professional services and other fees

2,108,307

-

2,108,307

Technical engineering fees

1,980,186

-

1,980,186

Patient fees

-

1,207,343

1,207,343

Telehealth fees

-

1,003,510

1,003,510

Institutional fees

-

6,880

6,880

Total revenues

8,203,619

2,217,733

10,421,352

Cost of revenues

2,241,096

1,002,676

3,243,772

Segment gross margin

5,962,523

1,215,057

7,177,580

Less (1):

Compensation and related benefits

3,751,534

876,558

4,628,092

General and administrative expenses

1,854,796

2,397,735

4,252,531

Goodwill impairment charges

Transaction expenses

93,000

-

93,000

Goodwill impairment

-

56,675,210

56,675,210

Segment operating income (loss)

263,193

(58,734,446)

(58,471,253)

Reconciliation to income (loss) before income taxes:

Unallocated corporate overhead expenses

(3,679,592)

Interest expense

(211,459)

Other income

504

Change in fair value of financial instruments

6,176,097

Loss on extinguishment of debt

(2,513,234)

Loss on issuance of financial instruments

(645,979)

Loss before benefit from (provision for) income taxes

($ 59,344,916)

(1) The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM. 

For the Year Ended December 31, 2023

Technology

Telehealth (1)

Total

Revenues:

Subscription fees

$ 4,044,807

$ -

$ 4,044,807

Professional services and other fees

1,063,114

-

1,063,114

Technical engineering fees

657,968

-

657,968

Total revenues

5,765,889

-

5,765,889

Cost of revenues

1,933,195

-

1,933,195

Segment gross margin:

3,832,694

-

3,832,694

Less (1):

Compensation and related benefits

4,417,028

-

4,417,028

General and administrative expenses

1,202,456

-

1,202,456

Transaction expenses

86,799

-

86,799

Segment operating loss

(1,873,589)

-

(1,873,589)

Reconciliation to loss before income taxes:

Interest expense

(191,323)

Other (expense) income, net

(20,114)

Change in fair value of embedded derivative

90,200

Gain on forgiveness of debt

107,862

Loss before benefit from (provision for) income taxes

($ 1,886,964)

(1) The Telehealth segment was first identified as a segment by the Company effective upon the close of the Business Combination in June 2024, as the Telehealth segment aligns with the legacy iDoc operating entity acquired at that time. 

The summary information regarding the reportable segment total assets at years ended December 31, 2024 and 2023 is as follows:

    

2024

    

2023

Total assets

Technology

$

1,503,995

$

805,791

Telehealth

18,271,724

Non-operating corporate

216,769

Total

$

19,992,488

$

805,791

Some additional summary information regarding the reportable segment depreciation and amortization and capital expenditures for the years ended December 31, 2024 and 2023 is as follows:

    

2024

    

2023

Depreciation and amortization

Technology

$

4,680

$

678

Telehealth

1,318,787

Total

$

1,323,467

$

678

    

2024

    

2023

Capital expenditures 

Technology

$

20,117

$

4,335

Telehealth

35,150

Total

$

55,267

$

4,335

    

2024

    

2023

Interest expense

 

  

 

  

Technology

$

77,128

$

191,323

Telehealth

 

133,131

 

Non-operating corporate

 

1,200

 

Total

$

211,459

$

191,323